Omega Fund Management, LLC

13F Portfolio Filings

  • Most recent 13F
    Q4 2024
  • Location
    boston, MA
  • CIK
    0001637359
  • Alternate names
    Omega Fund Management (US) Inc.
  • All SEC filings
Q4 2024
Quater
Holdings
VALUE
Top Holdings
Form Type
Date Filed
Filing Id

11

$120.71M
BICARA THERAPEUTICS INC, NUVB, REPL, LXEO
13F-HR
Feb 14, 2025
000095012325002355

11

$160.01M
BICARA THERAPEUTICS INC, NUVB, REPL, LXEO
13F-HR
Nov 14, 2024
000095012324011486

11

$134.97M
NUVB, LXEO, REPL, ENGN
13F-HR
Aug 14, 2024
000095012324008730

11

$155.01M
NUVB, LXEO, REPL, ENGN
13F-HR
May 14, 2024
000095012324005045

14

$123.44M
LXEO, REPL, NUVB, ENGN
13F-HR
Feb 14, 2024
000095012324002504

12

$108.88M
REPL, NUVB, IKNA, MORF
13F-HR
Nov 14, 2023
000095012323010476

12

$178.49M
REPL, NUVB, ALPN, MORF
13F-HR
Aug 14, 2023
000095012323007696

14

$153.32M
REPL, NUVB, MORF, ALPN
13F-HR
May 15, 2023
000095012323005263

16

$296.72M
IMGO, REPL, NUVB, MORF
13F-HR
Feb 13, 2023
000095012323002007

19

$273.06M
REPL, IMGO, NUVB, CINC
13F-HR
Nov 14, 2022
000095012322012070

21

$313.29M
REPL, NUVB, IMGO, MORF
13F-HR
Aug 15, 2022
000095012322009090

22

$488.61M
NUVB, REPL, IMGO, MORF
13F-HR
May 13, 2022
000095012322005699

22

$707.27M
NUVB, REPL, IMGO, MORF
13F-HR
Feb 14, 2022
000095012322002360

26

$891.38M
NUVB, REPL, KRON, MORF
13F-HR
Nov 15, 2021
000095012321015480

2

$279.25M
NUVB, SANA
NEW HOLDINGS
Nov 15, 2021
000095012321015607

21

$604.35M
REPL, MORF, KRON, IKNA
13F-HR
Aug 16, 2021
000095012321011084

2

$323.06M
NUVB, SANA
NEW HOLDINGS
Nov 15, 2021
000095012321015603

22

$734.16M
REPL, MORF, KRON, IKNA
13F-HR
May 17, 2021
000095012321006880

19

$666.88M
REPL, KRON, MORF, SPRB
13F-HR
Feb 16, 2021
000095012321002713

16

$369.66M
REPL, MORF, GOSS, IMUX
13F-HR
Nov 16, 2020
000095012320011928

15

$365.74M
REPL, MORF, GOSS, ARQT
13F-HR
Aug 17, 2020
000095012320009147

16

$241.63M
REPL, MORF, GOSS, ARQT
13F-HR
May 14, 2020
000095012320004802

14

$314.17M
GOSS, REPL, MORF, TRANSLATE BIO INC
13F-HR
Feb 13, 2020
000095012320001796

14

$324.01M
GOSS, REPL, MORF, TRANSLATE BIO INC
13F-HR
Nov 13, 2019
000095012319010754

15

$392.08M
GOSS, REPL, MORF, TRANSLATE BIO INC
13F-HR
Aug 13, 2019
000095012319007724

13

$311.89M
GOSS, REPL, TRANSLATE BIO INC, PRTK
NEW HOLDINGS
May 20, 2019
000095012319005615

12

$161.21M
REPL, TRANSLATE BIO INC, PRTK, OBSEVA SA
13F-HR
May 15, 2019
000095012319005079

14

$134.87M
REPL, TRANSLATE BIO INC, KZR, PRTK
13F-HR
Feb 11, 2019
000095012319001091

14

$211.38M
REPL, PRTK, TRANSLATE BIO INC, OBSEVA SA
13F-HR
Nov 7, 2018
000095012318010593

13

$135.52M
TRANSLATE BIO INC, PRTK, OBSEVA SA, KZR
13F-HR
Aug 2, 2018
000095012318007267

12

$101.75M
PRTK, SNNAQ, OBSEVA SA, JNCE
13F-HR
May 4, 2018
000095012318004151

12

$138.31M
PRTK, JUNO, SNNAQ, OBSEVA SA
13F-HR
Feb 5, 2018
000095012318000798

11

$176.76M
PRTK, JUNO, FGEN, SNNAQ
13F-HR
Nov 3, 2017
000095012317009490

11

$160.24M
PRTK, JUNO, FGEN, NABRIVA THERAPEUTICS PLC
13F-HR
Jul 26, 2017
000095012317006325

11

$153.84M
PRTK, JUNO, FGEN, EGLTQ
13F-HR
May 9, 2017
000095012317004097

12

$123.24M
PRTK, JUNO, EGLTQ, FGEN
13F-HR
Feb 10, 2017
000095012317001390

11

$130.99M
JUNO, PRTK, EGLTQ, FGEN
13F-HR
Nov 2, 2016
000095012316021058

11

$134.80M
JUNO, PRTK, EGLTQ, FGEN
13F-HR
Aug 3, 2016
000095012316018706

11

$144.17M
JUNO, PRTK, EGLTQ, FGEN
13F-HR
May 2, 2016
000095012316016121

10

$179.69M
JUNO, PRTK, EGLTQ, FGEN
13F-HR
Feb 10, 2016
000095012316013919

10

$177.61M
JUNO, PRTK, EGLTQ, FGEN
13F-HR
Nov 4, 2015
000095012315010742

7

$198.06M
JUNO, PRTK, EGLTQ, FGEN
13F-HR
Aug 10, 2015
000095012315008290

7

$231.25M
JUNO, PRTK, EGLTQ, FGEN
13F-HR
May 11, 2015
000095012315005268

7

$217.39M
PRTK, JUNO, FGEN, EGLTQ
13F-HR
Mar 23, 2015
000095012315004059